Antiviral antibodies produced by survivors of Ebola infection continue to evolve and improve after recovery, according to a study of immune responses in four people who received care at Emory University Hospital in 2014. High levels of neutralizing antibodies- thought to be key to protecting someone against deadly infection — didn’t appear in patients’ blood until months after they left the hospital.